People with nonalcoholic fatty liver disease cirrhosis fare worse before and after liver transplant surgery if they are not overweight than if they are, according to new research presented at the 2021 Liver Meeting.
“NAFLD is one of the leading etiologies of liver disease among adults awaiting liver transplantation, and non-overweight individuals with NAFLD represent a subset of patients with a distinct risk factor profile characterized by increased visceral adipose tissue, underlying